advertisement
Bio Imaging Technologies "buy," target price reduced
03/26/08 - Broadpoint Capital
NEW YORK, March 26 (newratings.com) - Analysts at Broadpoint Capital reiterate their "buy" rating on Bio Imaging Technologies Inc (BITI). The target price has been reduced from $12 to $11.
Share Recommend this article to a friend
add BITI to my stocks and get e-mail alerts on Bio-Imaging Technologies
News